Effects of anticancer agents on cell viability, proliferative activity and cytokine production of peripheral blood mononuclear cells-Reference-Cited by-同舟云学术

Effects of anticancer agents on cell viability, proliferative activity and cytokine production of peripheral blood mononuclear cells

Published:2013 Issue:1 Volume:52 Page:64-71
ISSN:0912-0009
Container-title:Journal of Clinical Biochemistry and Nutrition
language:en
Short-container-title:J. Clin. Biochem. Nutr.

Author:

Sakai Hiromi¹,Kokura Satoshi¹²,Ishikawa Takeshi¹²,Tsuchiya Reiko¹,Okajima Manabu¹,Matsuyama Tatsuzou¹,Adachi Satoko²,Katada Kazuhiro¹,Kamada Kazuhiro¹,Uchiyama Kazuhiko¹,Handa Osamu¹,Takagi Tomohisa¹,Yagi Nobuaki¹,Naito Yuji¹,Yoshikawa Toshikazu²

Affiliation:

1. Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine

2. Department of Cancer ImmunoCell Regulation, Kyoto Prefectural University of Medicine

Publisher

The Society for Free Radical Research Japan

Subject

Clinical Biochemistry,Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.jstage.jst.go.jp/article/jcbn/52/1/52_12-60/_pdf

Reference25 articles.

1. 1 AbdAlla EE, Blair GE, Jones RA, Sue-Ling HM, Johnston D. Mechanism of synergy of levamisole and fluorouracil: induction of human leukocyte antigen class I in a colorectal cancer cell line. J Natl Cancer Inst 1995; 87: 489–496.

2. 2 Bergmann-Leitner ES, Abrams SI. Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8⁺ cytotoxic T lymphocytes. Cancer Immunol Immunother 2001; 50: 445–455.

3. 3 Correale P, Del Vecchio MT, La Place M, et al. Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. J Immunother 2008; 31: 132–147.

4. 4 Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007; 179: 977–983.

5. 5 Hirooka Y, Ito A, Kawashima H, et al. A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Pancreas 2009; 38: e69–e74.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing cells to improve transport of nanomedicines;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

2. Potential applications of macrophages in cancer immunotherapy;Biomedicine & Pharmacotherapy;2024-09

3. Engineering macrophages and their derivatives: A new hope for antitumor therapy;Biomedicine & Pharmacotherapy;2024-08

4. Development of perioperative immune checkpoint inhibitor therapy for locally advanced esophageal squamous cell carcinoma;Future Oncology;2024-05-17

5. Advances in Engineered Macrophages: A New Frontier in Cancer Immunotherapy;Cell Death & Disease;2024-04-01